Launch week offerEnds in00h00m00s

annual Promonthly Pro

Carlee Moser

Senior Research Scientist

Harvard T.H. Chan School of Public Health

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (20)

Collaborators (7)

Vincent Marconi

Professor of Global Health

Emory University School of Medicine

UNITED STATES

David Boulware

University of Minnesota

UNITED STATES

Rachel Bender Ignacio

Associate Professor

Fred Hutchinson Cancer Research Center

UNITED STATES

Judith Currier

University of California, Los Angeles

UNITED STATES

Thomas A Murray

Associate Professor

University of Minnesota

UNITED STATES

Carolyn T. Bramante

University of Minnesota

UNITED STATES

Alba Grifoni

Research Assistant Professor

La Jolla Institute for Immunology

UNITED STATES

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Carlee Moser

Research Interests

Make your next move.

Explore related searches

Articles (20)

Collaborators (7)

Vincent Marconi

David Boulware

Rachel Bender Ignacio

Judith Currier

Thomas A Murray

Carolyn T. Bramante

Alba Grifoni

Make your next move.

Carlee Moser

Research Interests

Make your next move.

Explore related searches

Articles (20)

Evaluating Viral Load Sampling Schemes and Swabbing Methods for Optimal Surrogacy

The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death

Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy

Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study

Viral and Symptom Rebound Following Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial

Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2

SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19

SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback

Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial

Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral Therapy

ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients

Immune Status and SARS-CoV-2 Viral Dynamics

Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial

Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19

Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials

Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial

Variant-Specific Viral Kinetics in Acute COVID-19

Collaborators (7)

Vincent Marconi

David Boulware

Rachel Bender Ignacio

Judith Currier

Thomas A Murray

Carolyn T. Bramante

Alba Grifoni

Make your next move.